title: Interaction of the carbon monoxide-releasing molecule Ru(CO)3Cl(glycinate) (CORM-3) with Salmonella enterica serovar Typhimurium: in situ measurements of carbon monoxide binding by integrating cavity dual-beam spectrophotometry.
abstract: Carbon monoxide (CO) is a toxic gas that binds to haems, but also plays critical signalling and cytoprotective roles in mammalian systems; despite problems associated with systemic delivery by inhalation of the gas, it may be employed therapeutically. CO delivered to cells and tissues by CO-releasing molecules (CO-RMs) has beneficial and toxic effects not mimicked by CO gas; CO-RMs are also attractive candidates as novel antimicrobial agents. Salmonella enterica serovar Typhimurium is an enteropathogen causing gastroenteritis in humans. Recent studies have implicated haem oxygenase-1 (HO-1), the protein that catalyses the degradation of haem into biliverdin, free iron and CO, in the host immune response to Salmonella infection. In several studies, CO administration via CO-RMs elicited many of the protective roles of HO-1 induction and so we investigated the effects of a well-characterized water-soluble CO-RM, Ru(CO)3Cl(glycinate) (CORM-3), on Salmonella. CORM-3 exhibits toxic effects at concentrations significantly lower than those reported to cause toxicity to RAW 264.7 macrophages. We demonstrated here, through oxyhaemoglobin assays, that CORM-3 did not release CO spontaneously in phosphate buffer, buffered minimal medium or very rich medium. CORM-3 was, however, accumulated to high levels intracellularly (as shown by inductively coupled plasma MS) and released CO inside cells. Using growing Salmonella cultures without prior concentration, we showed for the first time that sensitive dual-beam integrating cavity absorption spectrophotometry can detect directly the CO released from CORM-3 binding in real-time to haems of the bacterial electron transport chain. The toxic effects of CO-RMs suggested potential applications as adjuvants to antibiotics in antimicrobial therapy.
authors.affiliation: Department of Molecular Biology & Biotechnology, The University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
authors.forename: Namrata
authors.initials: N
authors.lastname: Rana
authors.affiliation: Department of Molecular Biology & Biotechnology, The University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
authors.forename: Samantha
authors.initials: S
authors.lastname: McLean
authors.affiliation: Department of Chemistry, The University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
authors.forename: Brian E
authors.initials: BE
authors.lastname: Mann
authors.affiliation: Department of Molecular Biology & Biotechnology, The University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
authors.forename: Robert K
authors.initials: RK
authors.lastname: Poole
mesh_terms: D000900:Anti-Bacterial Agents / Q000378:metabolism*; D002248:Carbon Monoxide / Q000378:metabolism*; D045222:Electron Transport Chain Complex Proteins / Q000378:metabolism; D006418:Heme / Q000378:metabolism; D006801:Humans; D009942:Organometallic Compounds / Q000378:metabolism*; D011485:Protein Binding; D012486:Salmonella typhimurium / Q000187:drug effects* / Q000378:metabolism*; D013053:Spectrophotometry
chemical_list: D000900:Anti-Bacterial Agents; D045222:Electron Transport Chain Complex Proteins; D009942:Organometallic Compounds; C476530:tricarbonylchloro(glycinato)ruthenium(II); D006418:Heme; D002248:Carbon Monoxide